Lucas Actis-Goretta1, Tristan P Dew2, Antoine Lévèques1, Gema Pereira-Caro3, Maarit Rein1, Alexander Teml4, Christian Schäfer5, Ute Hofmann4, Matthias Schwab6, Michel Eichelbaum4, Alan Crozier7, Gary Williamson8. 1. Nestlé Research Center, Nestec Ltd, Lausanne, Switzerland. 2. Faculty of Life Sciences, Bradford School of Pharmacy, University of Bradford, Bradford, UK. 3. Department of Technology, Postharvest and Food Industry, IFAPA-Alameda del Obispo, Córdoba, Spain. 4. Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. 5. Department of Gastroenterology and Hepatology, Robert Bosch Hospital, Stuttgart, Germany. 6. Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany. 7. Department of Nutrition, University of California, Davis, CA, USA. 8. School of Food Science and Nutrition, University of Leeds, Leeds, UK.
Abstract
SCOPE: Hesperetin-7-O-rutinoside (hesperidin) reduces blood pressure in healthy volunteers but its intestinal absorption and metabolism are not fully understood. Therefore, we aimed to determine sites of absorption and metabolism of dietary flavanone glycosides in humans. METHODS AND RESULTS: Using a single-blind, randomized crossover design, we perfused equimolar amounts of hesperetin-7-O-rutinoside and hesperetin-7-O-glucoside directly into the proximal jejunum of healthy volunteers. We assessed the appearance of metabolites in the perfusate, blood and urine, to determine the sites of metabolism and excretion, and compared this to oral administration. The glucoside was rapidly hydrolyzed by brush border enzymes without any contribution from pancreatic, stomach, or other secreted enzymes, or from bacterial enzymes. Only ∼3% of the dose was recovered intact in the perfusate, indicating high absorption. A proportion was effluxed directly back into the perfused segment mainly in the form of hesperetin-3'-O-sulfate. In contrast, very little hydrolysis or absorption of hesperetin-7-O-rutinoside was observed with ∼80% recovered in the perfusate, no hesperetin metabolites were detected in blood and only traces were excreted in urine. CONCLUSION: The data elucidate the pathways of metabolism of dietary hesperidin in vivo and will facilitate better design of mechanistic studies both in vivo and in vitro.
RCT Entities:
SCOPE: Hesperetin-7-O-rutinoside (hesperidin) reduces blood pressure in healthy volunteers but its intestinal absorption and metabolism are not fully understood. Therefore, we aimed to determine sites of absorption and metabolism of dietary flavanone glycosides in humans. METHODS AND RESULTS: Using a single-blind, randomized crossover design, we perfused equimolar amounts of hesperetin-7-O-rutinoside and hesperetin-7-O-glucoside directly into the proximal jejunum of healthy volunteers. We assessed the appearance of metabolites in the perfusate, blood and urine, to determine the sites of metabolism and excretion, and compared this to oral administration. The glucoside was rapidly hydrolyzed by brush border enzymes without any contribution from pancreatic, stomach, or other secreted enzymes, or from bacterial enzymes. Only ∼3% of the dose was recovered intact in the perfusate, indicating high absorption. A proportion was effluxed directly back into the perfused segment mainly in the form of hesperetin-3'-O-sulfate. In contrast, very little hydrolysis or absorption of hesperetin-7-O-rutinoside was observed with ∼80% recovered in the perfusate, no hesperetin metabolites were detected in blood and only traces were excreted in urine. CONCLUSION: The data elucidate the pathways of metabolism of dietary hesperidin in vivo and will facilitate better design of mechanistic studies both in vivo and in vitro.
Authors: Julian K Aschoff; Ken M Riedl; Jessica L Cooperstone; Josef Högel; Anja Bosy-Westphal; Steven J Schwartz; Reinhold Carle; Ralf M Schweiggert Journal: Mol Nutr Food Res Date: 2016-09-12 Impact factor: 5.914
Authors: Anna Crescenti; Antoni Caimari; Juan María Alcaide-Hidalgo; Roger Mariné-Casadó; Rosa M Valls; Judit Companys; Patricia Salamanca; Lorena Calderón-Pérez; Laura Pla-Pagà; Anna Pedret; Antoni Delpino-Rius; Pol Herrero; Iris Samarra; Lluís Arola; Rosa Solà; Josep M Del Bas Journal: Nutrients Date: 2022-06-15 Impact factor: 6.706
Authors: Marcel Mengelers; Marco Zeilmaker; Arnau Vidal; Marthe De Boevre; Sarah De Saeger; Rudolf Hoogenveen Journal: Toxins (Basel) Date: 2019-08-08 Impact factor: 4.546
Authors: Anna Mas-Capdevila; Joan Teichenne; Cristina Domenech-Coca; Antoni Caimari; Josep M Del Bas; Xavier Escoté; Anna Crescenti Journal: Nutrients Date: 2020-05-20 Impact factor: 5.717